SCHEMBL8346261

SCHEMBL8346261

CCOc1ccc(NC(=S)N[C@H](CC(C)C)C(=O)Nc2c(C)cccc2C)c([N+](=O)[O-])c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.51
ALDH1A1 P00352 5/20 0.51
MEN1 O00255 5/20 0.51
NPSR1 Q6W5P4 3/20 0.51
HPGD P15428 3/20 0.51
CYP1A2 P05177 2/20 0.51
CYP2C9 P11712 2/20 0.51
LMNA P02545 2/20 0.51
CYP2C19 P33261 1/20 0.51
SMN1; SMN2 Q16637 6/20 0.49
MAPT P10636 6/20 0.49
RAB9A P51151 4/20 0.49
NPC1 O15118 3/20 0.49
POLB P06746 2/20 0.49
MAPK1 P28482 2/20 0.49
PKM P14618 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
RECQL P46063 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713989 1.00 KMT2A (0.51) KMT2AALDH1A1MEN1NPSR1HPGD
SCHEMBL6714168 0.92 MEN1 (0.56) KMT2AALDH1A1MEN1NPSR1CYP2C9
SCHEMBL6714162 0.92 MEN1 (0.56) KMT2AALDH1A1MEN1NPSR1CYP2C9
SCHEMBL6718999 0.90 MEN1 (0.43) KMT2AALDH1A1MEN1NPSR1HPGD
SCHEMBL8345944 0.90 MEN1 (0.43) KMT2AALDH1A1MEN1NPSR1HPGD
SCHEMBL6718995 0.89 MEN1 (0.45) KMT2AALDH1A1MEN1NPSR1HPGD
SCHEMBL6716681 0.85 SMN1; SMN2 (0.55) KMT2AALDH1A1MEN1NPSR1HPGD
SCHEMBL6713993 0.81 MAPT (0.48) KMT2AALDH1A1MEN1NPSR1HPGD
SCHEMBL6716241 0.77 SMN1; SMN2 (0.55) KMT2AALDH1A1MEN1LMNASMN1; SMN2
SCHEMBL6716665 0.77 SMN1; SMN2 (0.56) KMT2AALDH1A1MEN1NPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004022534-A1 ARYLGLYCINE DERIVATIVES FOR USE AS GLYCINE TRANSPORT INHIBITORS NPS ALLELIX CORP. (CA) 2004-03-18 WO disclosed